Jeffrey S. Painter

1.8k total citations
28 papers, 1.3k citations indexed

About

Jeffrey S. Painter is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Jeffrey S. Painter has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 14 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Jeffrey S. Painter's work include Acute Myeloid Leukemia Research (13 papers), Immune Cell Function and Interaction (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Jeffrey S. Painter is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Immune Cell Function and Interaction (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Jeffrey S. Painter collaborates with scholars based in United States, Germany and China. Jeffrey S. Painter's co-authors include William S. Dalton, Terry H. Landowski, I Buyuksal, Ning Qu, Pearlie K. Epling‐Burnette, Fanqi Bai, Alan F. List, JianXiang Zou, David Boulware and Julie Y. Djeu and has published in prestigious journals such as Blood, Oncogene and Leukemia.

In The Last Decade

Jeffrey S. Painter

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey S. Painter United States 16 635 497 474 344 297 28 1.3k
Fanqi Bai United States 13 637 1.0× 307 0.6× 290 0.6× 240 0.7× 305 1.0× 24 1.0k
Bryan Ciccarelli United States 13 302 0.5× 316 0.6× 530 1.1× 320 0.9× 264 0.9× 34 1.1k
Andrea G.S. Buggins United Kingdom 19 628 1.0× 224 0.5× 332 0.7× 474 1.4× 251 0.8× 33 1.1k
Virginia Snell United States 14 387 0.6× 278 0.6× 542 1.1× 209 0.6× 391 1.3× 19 1.1k
Geneviève Fiol France 13 489 0.8× 412 0.8× 489 1.0× 87 0.3× 328 1.1× 16 1.1k
Charis E. Teh Australia 16 404 0.6× 148 0.3× 428 0.9× 234 0.7× 190 0.6× 34 946
S Hirosawa Japan 18 305 0.5× 362 0.7× 470 1.0× 231 0.7× 310 1.0× 34 1.1k
Ahmed Amine Khamlichi France 22 714 1.1× 155 0.3× 1.0k 2.2× 170 0.5× 166 0.6× 48 1.6k
Piernicola Boccuni United States 18 389 0.6× 602 1.2× 1.0k 2.1× 178 0.5× 195 0.7× 24 1.6k
Michele Bianchini Argentina 19 432 0.7× 236 0.5× 425 0.9× 159 0.5× 421 1.4× 45 1.2k

Countries citing papers authored by Jeffrey S. Painter

Since Specialization
Citations

This map shows the geographic impact of Jeffrey S. Painter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Painter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Painter more than expected).

Fields of papers citing papers by Jeffrey S. Painter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Painter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Painter. The network helps show where Jeffrey S. Painter may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Painter

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Painter. A scholar is included among the top collaborators of Jeffrey S. Painter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Painter. Jeffrey S. Painter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Christopher A., Jason Walker, Robert S. Fulton, et al.. (2022). Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence. Journal of Molecular Diagnostics. 24(3). 219–223. 14 indexed citations
2.
Padron, Eric, Jeffrey S. Painter, Sateesh Kunigal, et al.. (2013). GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia. Blood. 121(25). 5068–5077. 108 indexed citations
3.
Liu, Yang, Adam W. Mailloux, Dana E. Rollison, et al.. (2012). Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency. Leukemia. 27(4). 897–906. 17 indexed citations
4.
5.
Bai, Fanqi, Alejandro Villagra, Jeffrey S. Painter, et al.. (2011). Tipifarnib-mediated suppression of T-bet-dependent signaling pathways. Cancer Immunology Immunotherapy. 61(4). 523–533. 4 indexed citations
6.
Rollison, Dana E., P.K. Epling-Burnette, Jong Y. Park, et al.. (2011). Telomere length in myelodysplastic syndromes. Leukemia & lymphoma. 52(8). 1528–1536. 43 indexed citations
7.
Padron, Eric, Jeffrey S. Painter, Adam W. Mailloux, et al.. (2011). GM-CSF Signaling Abnormalities in Chronic Myelomonocytic Leukemia. Blood. 118(21). 1713–1713. 2 indexed citations
8.
Zou, JianXiang, Dana E. Rollison, David Boulware, et al.. (2009). Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome. Leukemia. 23(7). 1288–1296. 45 indexed citations
9.
Komrokji, Rami S., Jeffrey S. Painter, Dana E. Rollison, et al.. (2009). Positive Impact of T-Cell Clonal Expansion On Overall Survival in Patients with High-Risk Myelodysplastic Syndromes.. Blood. 114(22). 1572–1572. 1 indexed citations
10.
Epling‐Burnette, Pearlie K., Lubomir Sokol, Xianhong Chen, et al.. (2008). Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling. Blood. 112(12). 4694–4698. 33 indexed citations
11.
Zou, JianXiang, Dana E. Rollison, David Boulware, et al.. (2008). Altered Naive and Memory T Cell Homeostasis and Immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic Syndrome. Blood. 112(11). 3647–3647. 1 indexed citations
12.
Powers, John J., et al.. (2008). A Comprehensive Lymphocyte Analysis of Dasatinib Treated Chronic Myelogenous Leukemia Patients Reveals T-Cell Oligoclonality.. Blood. 112(11). 1114–1114. 2 indexed citations
13.
Epling‐Burnette, Pearlie K., Jeffrey S. Painter, Dana E. Rollison, et al.. (2007). Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome. Leukemia. 21(4). 659–667. 94 indexed citations
14.
Bai, Fanqi, JianXiang Zou, Wei Sheng, et al.. (2007). Th2 Polarization Induced by the Farnesyltransferase Inhibitor Tipifarnib (Zarnestra®, R115777) through Suppression of T-bet.. Blood. 110(11). 1331–1331. 1 indexed citations
15.
Yang, Jun, Pearlie K. Epling‐Burnette, Jeffrey S. Painter, et al.. (2007). Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood. 111(3). 1610–1616. 63 indexed citations
16.
Epling‐Burnette, Pearlie K., Fanqi Bai, Sheng Wei, et al.. (2004). ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene. 23(57). 9220–9229. 61 indexed citations
17.
Hazlehurst, Lori, Steven A. Enkemann, Craig A. Beam, et al.. (2003). Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.. PubMed. 63(22). 7900–6. 107 indexed citations
18.
Landowski, Terry H., Lynn C. Moscinski, Rachel M. Burke, et al.. (2001). CD95 Antigen Mutations in Hematopoietic Malignancies. Leukemia & lymphoma. 42(5). 835–846. 22 indexed citations
19.
Landowski, Terry H., Kenneth H. Shain, Marc M. Oshiro, et al.. (1999). Myeloma Cells Selected for Resistance to CD95-Mediated Apoptosis Are Not Cross-Resistant to Cytotoxic Drugs: Evidence for Independent Mechanisms of Caspase Activation. Blood. 94(1). 265–274. 51 indexed citations
20.
Landowski, Terry H., Ning Qu, I Buyuksal, Jeffrey S. Painter, & William S. Dalton. (1997). Mutations in the Fas Antigen in Patients With Multiple Myeloma. Blood. 90(11). 4266–4270. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fanqi Bai Breakdown of academic impact, for papers by Bryan Ciccarelli Breakdown of academic impact, for papers by Andrea G.S. Buggins Breakdown of academic impact, for papers by Virginia Snell Breakdown of academic impact, for papers by Geneviève Fiol Breakdown of academic impact, for papers by Charis E. Teh Breakdown of academic impact, for papers by S Hirosawa Breakdown of academic impact, for papers by Ahmed Amine Khamlichi Breakdown of academic impact, for papers by Piernicola Boccuni Breakdown of academic impact, for papers by Michele Bianchini
Rankless by CCL
2026